Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

Anne-Ségolène Cottereau (1) , Hélène Lanic (2) , Sylvain Mareschal (3) , Michel Meignan (4) , Pierre Vera (5, 6) , Hervé Tilly (3) , Fabrice Jardin (3) , Stéphanie Becker (5, 6)

1 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
2 Service d'Hématologie
3 GPL - Groupe d'étude des proliférations lymphoïdes
4 Hôpital Henri Mondor
5 Service de médecine nucléaire [Rouen]
6 QuantIF-LITIS - Equipe Quantification en Imagerie Fonctionnelle

The prognostic impact of total metabolic tumor volume (TMTV) measured on pretreatment (18)F-FDG PET/CT and its added value to molecular characteristics was investigated in patients with diffuse large B-cell lymphoma (DLBCL).

Domaines: Cancer

Anne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, Michel Meignan, Pierre Vera, et al.. Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma. Clinical Cancer Research, 2016, 22 (15), pp.3801 - 3809. ⟨10.1158/1078-0432.CCR-15-2825⟩. ⟨hal-01644008⟩